0ab0fbe6 03ce 43f7 91a7 2e3ceb598bde

2MinuteMedicine

1. No significant difference in severe urinary tract infections was observed between patients starting SGLT-2 inhibitors for type 2 diabetes, compared to DPP-4 inhibitors or GLP-1 agonists.

2. These findings contrast with the significantly higher rates of urinary tract infections observed in patients taking SGLT-2 inhibitors compared to those taking placebo in randomized trials.

Evidence Rating Level: 2 (Good)

Click to read the study summary at 2 Minute Medicine

More about this case

ResolvedVerified literature

Why you should join Figure 1

• Share your knowledge with our global community of healthcare professionals
• Get help from experts in your field
• Learn from our library of real-world cases and quizzes

Similar cases

\1. In this retrospective observational study, the authors observed that residing in a disadvantaged neighborhood and being discharged from a safety-net hospital were independently associated with an increased 30-day risk of readmission.
2. There was a higher association observed between readmission risk and the hospital’s safety-net index compared to the patient’s neighborhood disadvantage status.
Evidence Rating Level: 2 (Good)](https://app.figure1.com/case-detail/1878afce-17c6-4fb8-a118-de62cfe79036)

\

April 6, 2020

In a paper published in the preprint journal medRxiv, researchers in Wuhan, China analyzed medical records of patients hospitalized with confirmed SARS-CoV-2 infection. They separated patients with both covid-19 and high blood pressure (hypertension) into two groups: patients who had been prescribed the antihypertensives “ACE inhibitors” and “ARBs,” and patients who had not been prescribed either of these medications. The question: do ACE inhibitors or ARBs have any effect, good or bad, on covid-19 infection? As previously covered in Brief19, experts have debated the use of these medications.

In this new study, researchers found that patients taking ACE inhibitors and ARBs were much less likely to develop “very severe” covid-19, and also had lower death rates. Does this mean that patients who have their elevated blood pressure under control have a better chance at good outcomes? It’s possible. High blood pressure appears to be a risk factor for poorer outcomes. Alternatively, might these medications even actively interrupt the virus’ attempt to enter cells, as we have covered? Too soon to say. However, these data do provide some preliminary evidence that patients already taking either an ACE inhibitor or an ARB for high blood pressure may not need to stop taking these medications if they become infected with SARS-CoV-2, as some experts have suggested might be necessary. Shared with permission from Brief19, a daily review of #covid-19 research and policy.

\A 52-year-old man presented with a 20-minute history of chest pain radiating to the left shoulder and neck, associated with dyspnea and diaphoresis.
He had a history of hypertension, long-term smoking, and a sedentary lifestyle.
On physical examination, bibasilar crackles were noted on lung auscultation. An electrocardiogram (ECG) was performed in the primary care setting, and the patient was promptly referred to the emergency department.](https://app.figure1.com/case-detail/ae0fe999-6875-4474-94f0-ad823dbb9b3a)

\A 28-year-old woman presented with a 3-day history of intense pruritus over the lower back. She reported no recent travel or exposure to new environments. She cares for a small kennel with approximately eight dogs rescued from the streets.
Physical examination revealed multiple small vesicles, some clustered and others scattered, predominantly involving the lumbar region and the left gluteal area.](https://app.figure1.com/case-detail/c271070f-2bc7-4052-9895-635277e1a7d5)

\A 4-month-old male infant presented with skin lesions localized to the chin for the past 3 days. Physical examination revealed multiple small pustules with surrounding inflammatory signs on the chin, along with a few scattered papules on the chest.](https://app.figure1.com/case-detail/48f41642-b9db-4089-b120-a94ee52328de)

70 yo WF with 20y hx HTN lost 21 lbs on a semaglutide but still BMI over 30, shows drop in BP when standing, stabilizing at 102-116 systolic, 65-75 diastolic. Discontinued all HTN meds x 30 days and no episodes of HTN. Could a small weight loss like this cause a drop to normal BP? Has anyone heard of a side effect of lowering BP?](https://app.figure1.com/case-detail/636fd008-29e2-47f4-8ba4-fbee9d527051)